Remove mandatory retirement' age for medical teachers: Dr Edmond Fernandes

[email protected] (CD Network)
June 10, 2016

Mangaluru, Jun 10: Dr Edmond Fernandes, CEO, Center for Health and Development [CHD-India] has written to Bhanu Pratap Sharma, Secretary, Health and Family Welfare, Government of India urging to remove mandatory retirement' age for medical teachers in private and Government medical colleges and Universities.

edmond

Considering the acute shortage of doctors in the country, which is way below the WHO recommended doctor patient ratio, he said the senior doctors will be instrumental to guide quality control needed by accreditation councils like NAAC, NABH and improve the overall development of health sector and human resources etc.

In the letter, Dr Edmond mentioned that employment should be seen as a human right which ensures independence, social security and promotes a sense of dignity and self-worth.

Setting a time-line for retirement at 70 is obsolete and unfair. The medical teachers post 70 should not aspire for posts of Heading departments and moving as examiners to other institutes, that should be clearly declared of in an undertaking and they should be assigned other development roles, he wrote.

He pointed out that a few medical teachers have dual MD degrees and a few might have Dual PHD's and it is important to cultivate these teachers without letting them go. If the mental faculty of the teacher is sound with physical movement at ease, there should be no retirement as such. Ontario Human Rights Commission, advocated and came up with the enlightened decision to remove mandatory retirement on 12th December, 2006, many other countries have followed suit. He has appealed to the Secretary to table this for immediate solution.

The letter has been copied to Dr Jayshree Mehta, President, Medical Council of India and Dr Shalini Rajneesh, Principal Secretary, Health and Family Welfare, Government of Karnataka.

Comments

Althaf
 - 
Friday, 10 Jun 2016

good job, u may get help from UT Khader.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
June 23,2020

Mangaluru, Jun 23: An elderly person, who was undergoing treatment for covid-19 in Mangaluru, breathed his last on today. 

The victim, identified by number P-6282, was a 70-year-old man. He had returned from Bengaluru on June 7. 

He was suffering asthma and pneumonia. He had Severe Acute Respiratory Infection (SARI) symptoms and was hence admitted to the designated covid-19 hospital in Mangaluru on June 12. 

His condition continued to worsen and today he breathed his last, sources said.

With this the total number the deaths of covid-19 patients in Dakshina Kannada district mounted to 9.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 1,2020

Bengaluru, Jul 1: Faced with increasing number of COVID-19 cases in the State Capital, Chief Justice of Karnataka High Court Justice A S Okha has decided the Court to function online.

Registrar General Rajendra Badamikar, in the notice issued here on Wednesday, based on order of the Chief Justice, stated that the emergency cases will be conducted through video conference until the next order.

The order also specifies that only the principal seat (Bengaluru) will be conducting proceedings online. High Court benches at Dharwad and Kalaburagi will continue to function as usual.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.